Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms

Journal of Medical Imaging and Radiation Oncology

Volumn 57, Issue 3, 2013, Pages 274-282

  Akay, Sinan ^a   Kocaoglu, Murat ^a   Emer, Ozdes ^a   Battal, Bilal ^a   Arslan, Nuri ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

diffusion weighted imaging; metastasis; neoplasm; PET CT; WB DWIBS

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; WHOLE BODY MRI;

ADULT; AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84878621907     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/1754-9485.12026     Document Type: Article

References (29)

1. Schmidt GP, Kramer H, Reiser MF, Glaser C,. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Top Magn Reson Imaging 2007; 18: 193-202.
2. Metser U, Miller E, Lerman H, Lievshitz G, Avital S, Even-Sapir E,. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006; 47: 32-37.
3. von Schulthess GK, Steinert HC, Hany TF,. Integrated PET/CT: current applications and future directions. Radiology 2006; 238: 405-422.
4. Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK,. Whole-body turbo STIR MR imaging in unknown primary tumour detection. J Magn Reson Imaging 1998; 8: 751-753.
5. Hargaden G, O'Connell M, Kavanagh E, Powel T, Ward R, Eustace S,. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. AJR Am J Roentgenol 2003; 180: 247-252.
6. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M,. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282.
7. Mürtz P, Krautmacher C, Träber F, Gieseke J, Schild HH, Willinek WA,. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007; 17: 3031-3037.
8. Manenti G, Cicciò C, Squillaci E, et al. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: comparison with PET-CT. Eur J Radiol 2011; 81: 1917-1925.
9. Mürtz P, Kaschner M, Träber F, et al. Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0T. Eur J Radiol 2011; 81: 3614-3623.
10. Dietrich O, Reiser MF, Schoenberg SO,. Artifacts in 3-T MRI: physical background and reduction strategies. Eur J Radiol 2008; 65: 29-35.
11. Horie T, Ogino T, Muro I, et al. Optimization of fat suppression for 3.0 T DWIBS. In: Proceedings of the 17th ISMRM. 2009.
12. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002; 12: 2091-2099.
13. Ichikawa T, Erturk SM, Motosugi U, et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006; 187: 181-184.
14. Ichikawa T, Erturk SM, Motosugi U, et al. High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol 2007; 188: 409-414.
15. Xu X, Ma L, Zhang JS, et al. Feasibility of whole body diffusion weighted imaging in detecting bone metastasis on 3.0 T MR scanner. Chin Med Sci J 2008; 23: 151-157.
16. Kwee TC, Takahara T, Vermoolen MA, Bierings MB, Mali WP, Nievelstein RA,. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol 2010; 40: 1592-1602; quiz 1720-1.
17. Radford JA, Cowan RA, Flanagan M, et al. The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol 1988; 6: 940-946.
18. Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94: 429-433.
19. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A,. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006; 16: 1468-1477.
20. Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J,. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009; 72: 381-387.
21. Kwee TC, Takahara T, Luijten PR, Nievelstein RA,. ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010; 75: 215-220.
22. Mürtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH,. Abdomen: diffusion-weighted MR imaging with pulse-triggered single-shot sequences. Radiology 2002; 224: 258-264.
23. Nasu K, Kuroki Y, Sekiguchi R, Kazama T, Nakajima H,. Measurement of the apparent diffusion coefficient in the liver: is it reliable index for hepatic disease diagnosis? Radiat Med 2006; 24: 438-444.
24. Nasu K, Kuroki Y, Sekiguchi R, Nawano S,. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006; 5: 129-136.
25. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130.
26. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007; 188: 1001-1008.
27. Zhang Y, Liang BL, Gao L, Zhong JL, Ye RX, Shen J,. Preliminary study of a lymph nodes imaging: diffusion-weighted MRI with STIR-EPI. Zhonghua Zhong Liu Za Zhi 2007; 29: 70-73.
28. Wang N, Zhang M, Sun T, et al. A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid positron emission computed tomography on detecting lesions in oncologic clinics. Eur J Radiol 2011; 81: 1662-1666.
29. Stecco A, Romano G, Negru M, et al. Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med 2009; 114: 1-17.